Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 4, 2011, Pages 398-407

  Karmakar, Surajit ^a   Choudhury, Subhasree Roy ^a   Banik, Naren L ^b   Ray, Swapan K ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; Calpain; Caspases; Diallyl disulfide; Diallyl sufide; Neuroblastoma

Indexed keywords

ALLYL SULFIDE; CASPASE; CASPASE 3; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CELL CYCLE PROTEIN 20; CHECKPOINT KINASE 1; CYCLIN B1; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR 5; DIALLYL DISULFIDE; DIALLYL TRISULFIDE; ENDONUCLEASE G; GARLIC EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MATRIX METALLOPROTEINASE; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNINDEXED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CALCIUM CELL LEVEL; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL MEMBRANE PERMEABILITY; CELL STRAIN HL 60; CHROMATIN CONDENSATION; DNA FRAGMENTATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GARLIC; HUMAN; MITOCHONDRION; MITOSIS INHIBITION; MOLECULAR MECHANICS; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 79958157741     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011795677553     Document Type: Review

References (95)

1. Brodeur, G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer., 2003, 3, 203-216.
2. Mueller, S.; Matthay, K.K. Neuroblastoma: biology and staging. Curr. Oncol. Rep., 2009, 11, 431-438.
3. Maris, J.M.; Hogarty, M.D.; Bagatell, R.; Cohn, S.L. Neuroblastoma. Lancet, 2007, 369, 2106-2120.
4. Ogawa, S.; Takita, J.; Sanada, M.; Hayashi, Y. Oncogenic mutations of ALK in neuroblastoma. Cancer Sci., 2011, 102, 302-308.
5. Carén, H.; Djos, A.; Nethander, M.; Sjöberg, R.M.; Kogner, P.; Enström, C.; Nilsson, S.; Martinsson, T. Identification of epigeneti-cally regulated genes that predict patient outcome in neuroblastom. BMC Cancer, 2011, 11, 66.
6. Jiang, M.; Stanke, J.; Lahti, J.M. The connections between neural crest development and neuroblastoma. Curr. Top. Dev. Biol., 2011, 94, 77-127.
7. Maris, J.M.; Matthay, K.K. Molecular biology of neuroblastoma. J. Clin. Oncol., 1999, 17, 2264-2279.
8. Goldschneider, D.; Horvilleur, E.; Plassa, L.F.; Guillaud-Bataille, M.; Million, K.; Wittmer-Dupret, E.; Danglot, G.; de Thé, H.; Bé-nard, J.; May E.; Douc-Rasy, S. Expression of C-terminal deleted p53 isoforms in neuroblastoma. Nucleic Acids Res., 2006, 34, 5603-5612.
9. Cole, K. A.; Huggins, J.; Laquaglia, M.; Hulderman, C. E.; Russell, M. R.; Bosse, K.; Diskin, S. J.; Attiyeh, E. F.; Sennett, R.; Norris, G.; Laudenslager, M.; Wood, A. C.; Mayes, P. A.; Jagannathan, J.; Winter, C.; Mosse, Y. P.; Maris, J. M. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 3336-3341.
10. Janardhanan, R.; Banik, N.L.; Ray, S.K. N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53. Biochem. Pharmacol., 2009, 78, 1105-1114.
11. Grotzer, M.A.; Castelletti, D.; Fiaschetti, G.; Shalaby, T.; Arcaro, A. Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Curr. Can. Drug Targ., 2009, 9, 176-188.
12. Ho, R.; Eggert, A.; Hishiki, T.; Minturn, J.E.; Ikegaki, N.; Foster, P.; Camoratto, A.M.; Evans, A.E.; Brodeur, G.M. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res., 2002, 62, 6462-6466.
13. Jaattela, M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene, 2004, 23, 2746-2756.
14. Lacour, S.; Micheau, O.; Hammann, A.; Drouineaud, V.; Tschopp, J.; Solary, E.; Dimanche-Boitrel, M.T. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells. Oncogene, 2003, 22, 1807-1816.
15. Barnhart, B.C.; Alappat, E.C.; Peter, M.E. The CD95 type I/type II model. Semin. Immunol., 2003, 15, 185-193.
16. Kim, R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer, 2005, 103, 1551-1560.
17. Roy Choudhury, S.; Karmakar, S.; Banik, N.L.; Ray, S.K. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. Invest. New Drugs, 2010, 28, 812-824.
18. Shibata, M.; Hattori, H.; Sasaki, T.; Gotoh, J.; Hamada, J.; Fukuuchi, Y. Activation of caspase-12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice. Neuroscience, 2003, 118, 491-499.
19. Karmakar, S.; Choudhury, S.R.; Banik, N.L.; Ray, S.K. Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts. Neuroscience, 2009, 163, 286-295.
20. Nieto-Miguel, T.; Fonteriz, R.I.; Vay, L.; Gajate, C.; López-Hernández, S.; Mollinedo, F. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res., 2007, 67, 10368-10378.
21. Karmakar, S.; Weinberg, M.S.; Banik, N.L.; Patel, S.J.; Ray, S.K. Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience, 2006, 141, 1265-1280.
22. Takano, J.; Tomioka, M.; Tsubuki, S.; Higuchi, M.; Iwata, N.; Itohara, S.; Maki, M.; Saido, T.C. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem., 2005, 280, 16175-16184.
23. Tsujimoto, Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J. Cell Physiol., 2003, 195, 158-167.
24. Cregan, S.P.; Dawson, V.L.; Slack, R.S. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene, 2004, 23, 2785-2796.
25. Weiss, J.N.; Korge, P.; Honda, H.M.; Ping, P. Role of the mitochondrial permeability transition in myocardial disease. Circ. Res., 2003, 93, 292-301.
26. Dole, M.; Nuñez, G.; Merchant, A.K.; Maybaum, J.; Rode, C.K.; Bloch C.A.; Castle, V.P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res., 1994, 54, 3253-3259.
27. Chen, J.; Freeman, A.; Liu, J.; Dai Q.; Lee, R.M. The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195. Mol. Cancer Ther., 2002,1, 961-967.
28. Kluck, R.M.; Bossy-Wetzel, E.; Green, D.R.; Newmeyer, D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 1997, 275, 1132-1136.
29. Sakahira, H.; Enari, M.; Nagata, S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature, 1998, 391, 96-99.
30. Du, C; Fang, M.; Li, Y.; Li, L.; Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 2000, 102, 33-42.
31. Verhagen, A.M.; Ekert, P.G.; Pakusch, M.; Silke, J.; Connolly, L.M.; Reid, G.E.; Moritz, R.L.; Simpson, R.J.; Vaux, D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 2000, 102, 43-53.
32. Liu, Z.; Sun, C; Olejniczak, E.T.; Meadows, R.P.; Betz, S.F.; Oost, T.; Herrmann, J.; Wu, J.C.; Fesik, S.W. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature, 2000, 408, 1004-1008.
33. Wang, C.Y.; Mayo, M.W.; Korneluk, R.G.; Goeddel, D.V.; Baldwin, A.S. NF-kB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 1998, 281, 1680-1683.
34. Notarbartolo, M.; Poma, P.; Perri, D.; Dusonchet, L.; Cervello, M.; D'Alessandro, N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett., 2005, 224, 53-65.
35. Zou, T.; Rao, J.N.; Guo, X.; Liu, L.; Zhang, H.M.; Strauch, E.D.; Bass, B.L.; Wang, J.Y. NF-KB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am. J. Physiol. Cell Physiol., 2004, 286, C1009-1018.
36. Song, Z.; Yao, X.; Wu, M. Direct interaction between surviving and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during Taxol-induced apoptosis. J. Biol. Chem., 2003, 278, 23130-23140.
37. Hasenjäger, A.; Gillissen, B.; Müller, A.; Normand, G.; Hemmati, P.G.; Schuler, M.; Dörken, B.; Daniel, P. T. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells. Oncogene, 2004, 23, 4523-4535.
38. Yang, Q. H.; Church-Hajduk, R.; Ren, J.; Newton, M.L.; Du, C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev., 2003,17, 1487-1496.
39. Suzuki, Y.; Takahashi-Niki, K.; Akagi, T.; Hashikawa, T.; Takaha-shi, R. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ., 2004,11, 208-216.
40. Cregan, S.P.; Fortin, A.; MacLaurin, J.G.; Callaghan, S.M.; Cec-coni, F.; Yu, S. W.; Dawson, T.M.; Dawson, V.L.; Park, D.S.; Kro-emer, G.; Slack, R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol., 2002,158, 507-517.
41. Polster, B.M.; Basañez, G.; Etxebarria, A.; Hardwick, J.M.; Nicholls, D.G. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J. Biol. Chem., 2005, 280, 6447-6454.
42. Yu, S. W.; Wang, H.; Poitras, M.F., Coombs, C; Bowers, W.J.; Federoff, H.J.; Poirier, G.G.; Dawson, T.M.; Dawson, V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 2002, 297, 259-263.
43. Zhang, J.; Dong, M.; Li, L.; Fan, Y.; Pathre, P.; Dong, J.; Lou, D.; Wells, J.M.; Olivares-Villagómez, D.; Van Kaer, L.; Wang, X.; Xu, M. Endonuclease G is required for early embryogenesis and normal apoptosis in mice. Proc. Natl. Acad. Sci. USA, 2003, 100, 15782-15787.
44. Li, L. Y.; Luo, X.; Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 2001, 412, 95-99.
45. Eisenberg, D.M.; Davis, R.B.; Ettner, S.L.; Appel, S.; Wilkey, S.; Von Rompay, M.; Kessler, R.C. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J. Am. Med. Asooc., 1998, 280, 1569-1575.
46. Park, E.J.; Pezzuto, J.M. Botanicals in cancer chemoprevention. Cancer Metastasis Rev., 2002, 21, 231-255.
47. Herman-Antosiewicz, A.; Singh, S.V. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat. Res., 2004, 555, 121-131.
48. Amagase, H.; Petesch, B.L.; Matsuura, H.; Kasuga, S.; Itakura, Y. Intake of garlic and its bioactive components. J. Nutr., 2001, 131, 955S-962S.
49. Wang, Y.B.; Qin, J.; Zheng, X.Y.; Bai, Y.; Yang, K.; Xie, L.P. Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via downregulation of Akt phosphorylation in human T24 bladder cancer cells. Phytomedicine, 2010, 17, 363-368.
50. Takahashi, S.; Hakoi, K.; Yada, H.; Hirose, M.; Ito, N.; Fukushima, S. Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis, 1992, 13, 1513-1518.
51. Busch, C.; Jacob, C.; Anwar, A.; Burkholz, T.; Aicha Ba, L.; Cerella, C.; Diederich, M.; Brandt, W.; Wessjohann, L.; Monte-narh, M. Diallylpolysulfides induce growth arrest and apoptosis. Int. J. Oncol., 2010, 36, 743-749.
52. Wargovich, M.J.; Imada, O.; Stephens, L.C. Initiation and post-initiation chemopreventive effects of diallyl sulfide in esophageal carcinogenesis. Cancer Lett., 1992, 64, 39-42.
53. Sparnins, V.L.; Barany, G.; Wattenberg, L.W. Effects of organosulfur compounds from garlic and onions on benzo[a] pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis, 1988, 9, 131-134.
54. Hayes, M.A.; Rushmore, T.H.; Goldberg, M.T. Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil. Carcinogenesis, 1987, 8, 1155-1157.
55. Suzui, N.; Sugie, S.; Rahman, K.M.; Ohnishi, M.; Yoshimi, N.; Wakabayashi, K.; Mori, H. Inhibitory effects of diallyl disulfide or aspirin on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats. Jpn. J. Cancer Res., 1997, 88, 705-711.
56. Arora, A.; Siddiqui, I.A.; Shukla, Y. Modulation of p53 in 7,12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice. Mol. Cancer Ther., 2004, 3, 1459-1466.
57. Wong, W.W.; Boutros, P.C.; Wasylishen, A.R.; Guckert, K.D.; O'Brien, E.M.; Griffiths, R.; Martirosyan, A.R.; Bros, C.; Jurisica, I.; Langler, R.F.; Penn, L.Z. Characterization of the apoptotic response of human leukemia cells to organosulfur compounds. BMC Cancer, 2010, 10, 351.
58. Nakagawa, H.; Tsuta, K.; Kiuchi, K.; Senzaki, H.; Tanaka, K.; Hioki, K.; Tsubura, A. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis, 2001, 22, 891-897.
59. Lee, B. C.; Park, B.H.; Kim, S.Y.; Lee, Y.J. Role of Bim in diallyl trisulfide-induced cytotoxicity in human cancer cells. Role of Bim in diallyl trisulfide-induced cytotoxicity in human cancer cells. J. Cell Biochem., 2011, 112, 118-127.
60. Hong, Y. S.; Ham, Y.A.; Choi, J.H.; Kim, J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp. Mol. Med., 2000, 32, 127-134.
61. Xiao, D.; Choi, S.; Johnson, D. E.; Vogel, V.G.; Johnson, C.S.; Trump, D.L.; Lee, Y. J.; Singh, S.V. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene, 2004, 23, 5594-6606.
62. Das, A.; Banik, N.L.; Ray, S.K. Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cys-teine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer, 2007, 110, 1083-1095.
63. Filomeni, G.; Aquilano, K.; Rotilio, G.; Ciriolo, M.R. Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res., 2003, 63, 5940-5949.
64. Karmakar, S.; Banik, N.L.; Patel, S.J.; Ray, S.K. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Apoptosis, 2007, 12, 671-684.
65. Aquilano, K.; Filomeni, G.; Baldelli, S.; Piccirillo, S.; De Martino, A.; Rotilio, G.; Ciriolo, M.R. Neuronal nitric oxide synthase protects neuroblastoma cells from oxidative stress mediated by garlic derivatives. J. Neurochem., 2007, 101, 1327-1337.
66. Aquilano, K.; Vigilanza, P.; Filomeni, G.; Rotilio, G.; Ciriolo, M.R. Tau dephosphorylation and microfilaments disruption are upstream events of the anti-proliferative effects of DADS in SH-SY5Y cells. J. Cell. Mol. Med., 2010, 14, 564-577.
67. Molinari, M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif., 2000, 33, 261-274.
68. Murray, A.W. Recycling the cell cycle: cyclins revisited. Cell, 2004, 116, 221-234.
69. cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr. Cancer, 1998, 30, 169-174.
70. cdc2 kinase activity through changes in complex formation and phosphorylation. Carcinogenesis, 2000, 21, 1129-1134.
71. Tan, L.M.; Zhang, M.X.; Luo, H.M.; Zeng, Y.Z.; Li, J.M.; Cui, Z.W.; Zhang, X. H.; Tang, S.S. The initiation of G2/M checkpoint by diallyl disulfide requires the activation of p38 MAP kinase in HL-60 cells. Zhonghua Xue Ye Xue Za Zhi, 2004, 25, 273-276.
72. Arunkumar, A.; Vijayababu, M.R.; Srinivasan, N.; Aruldhas, M.M.; Arunakaran, J. Garlic compound, diallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3. Mol. Cell. Biochem., 2006, 288, 107-113.
73. Xiao, D.; Herman-Antosiewicz, A.; Antosiewicz, J.; Xiao, H.; Brisson, M.; Lazo, J.S.; Singh, S.V. Diallyl trisulfide-induced G2-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphos-phorylation of Cdc 25 C. Oncogene, 2005, 24, 6256-6268.
74. Herman-Antosiewicz, A.; Singh, S.V. Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells. J. Biol. Chem., 2005, 280, 28519-28528.
75. Herman-Antosiewicz, A.; Stan, S.D.; Hahm, E.R.; Xiao, D.; Singh, S.V. Activation of a novel ataxia-telangiectasia mutated and Rad3 related/checkpoint kinase 1-dependent prometaphase checkpoint in cancer cells by diallyl trisulfide, a promising cancer chemopreven-tive constituent of processed garlic. Mol. Cancer. Ther., 2007, 6, 1249-1261.
76. Antosiewicz, J.; Herman-Antosiewicz, A.; Marynowski, S.W.; Singh, S.V. c-Jun NH2-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells. Cancer Res., 2006, 66, 5379-5386.
77. Sanchez, Y.; Wong, C.; Thoma, R.S.; Richman, R.; Wu, Z.; Piwnica-Worms, H.; Elledge, S.J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science, 1997, 277, 1497-1501.
78. Xiao, D.; Pinto, J.T.; Gundersen, G.G.; Weinstein, I.B. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol. Cancer Ther., 2005, 4, 1388-1398.
79. Welch, C.; Wuarin, L.; Sidell, N. Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro. Cancer Lett., 1992, 63, 211-219.
80. Kaufmann, S.H.; Gores, G.J. Apoptosis in cancer: cause and cure. Bioessays, 2000, 22, 1007-1017.
81. Ghobrial, I.M.; Witzig, T.E.; Adjei, A.A. Targeting apoptosis pathways in cancer therapy. CA. Cancer J. Clin., 2005, 55, 178-194.
82. Hengartner, M.O. The biochemistry of apoptosis. Nature, 2000, 407, 770-776.
83. Thornberry, N.; Lazebnick, Y. Caspases: enemies within. Science, 1998, 281, 1312-1316.
84. Chao, D.T.; Korsmeyer, S.J. BCL-2 family: regulators of cell death. Annu. Rev. Immunol., 1998, 16, 395-419.
85. Hong, Y.S.; Ham, Y.A.; Choi, J.H.; Kim, J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp. Mol. Med., 2000, 32, 127-134.
86. Nakagawa, H.; Tsuta, K.; Kiuchi, K.; Senzaki, H.; Tanaka, K.; Hioki, K.; Tsubura, A. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis, 2001, 22, 891-897.
87. Li, M.; Min, J.M.; Cui, J. R.; Zhang, L.H.; Wang, K.; Valette, A.; Davrinche, C.; Wright, M.; Leung-Tack, J. Z-ajoene induces apop-tosis of HL-60 cells: involvement of Bcl-2 cleavage. Nutr. Cancer, 2002, 42, 241-247.
88. Xiao, D.; Choi, S.; Johnson, D.E.; Vogel, V.G.; Johnson, C.S.; Trump, D.L.; Lee, Y.J.; Singh, S.V. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phos-phorylation of Bcl-2. Oncogene, 2004, 23, 5594-5606.
89. Kim, Y.; Xiao, D.; Xiao, H.; Powolny, A. A.; Lew, K.L.; Reilly, M.L.; Zeng, Y.; Wang, Z.; Singh, S.V. Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak. Mol. Cancer Ther., 2007, 6, 1599-1609.
90. Xiao, D.; Lew, K. L.; Kim, Y.; Zeng, Y.; Hahm, E.R.; Dhir, R.; Singh, S.V. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin. Cancer Res., 2006, 12, 6836-6843.
91. Xiao, D.; Singh, S.V. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis, 2006, 27, 533-540.
92. Sundaram, S.G.; Milner, J.A. Diallyl disulfide inhibits the proliferation of human tumor cells in culture. Biochim. Biophys. Acta., 1996, 1315, 15-20.
93. Sundaram, S.G.; Milner, J.A. Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis, 1996, 17, 669-673.
94. 2+ in diallyl disulfide-induced apoptotic cell death of HCT-15 cells. Exp. Mol. Med., 2002, 34, 250-257.
95. Sakamoto, K.; Lawson, L.D.; Milner, J.A. Allyl sulfides from garlic suppress the in vitro proliferation of human A549 lung tumor cells. Nutr. Cancer, 1997, 29, 152-156.